Solak Berna, Arslan Mustafa
Department of Dermatology, School of Medicine, Sakarya University, Sakarya, Turkey.
J Community Health. 2025 Jun;50(3):560-567. doi: 10.1007/s10900-025-01444-y. Epub 2025 Feb 2.
We aimed to evaluate awareness of HPV and its associated cancers, attitudes toward HPV vaccination, and vaccination rates in individuals with anogenital warts. This cross-sectional study was conducted at Sakarya University Training and Research Hospital using a questionnaire completed by individuals diagnosed with anogenital warts. A total of 105 respondents were included in the study, comprising 80 males (76.2%) and 25 females (23.8%). The mean age of participants was 34.7 ± 11.2 years. HPV awareness was 70.5%, while cervical cancer awareness was 38.1%. Women demonstrated significantly higher levels of HPV and cervical cancer awareness, as well as knowledge of Pap smear testing, compared to men. Women were also significantly more likely than men to express willingness to vaccinate their children against HPV (84.0% vs. 58.8%, p = 0.039). Higher education levels were associated with increased awareness of HPV, HPV vaccination, and willingness to vaccinate children. Physicians were the primary source of HPV-related information across the cohort. HPV vaccine awareness was 73.3%, but the overall vaccination rate was only 10.5%, with women showing significantly higher vaccination rates than men (24% vs. 6.2%, p = 0.021). The most commonly reported barriers to vaccination were cost (60%) and lack of information (45.7%). None of the participants had vaccinated their children. This study highlights that awareness of HPV and its vaccination is associated with gender and education level but does not translate into higher vaccination rates. Efforts should focus on targeting men and individuals with lower educational attainment by strengthening physicians' roles in public education. Incorporating HPV vaccination into national programs and implementing culturally tailored campaigns may effectively improve vaccination rates.
我们旨在评估尖锐湿疣患者对人乳头瘤病毒（HPV）及其相关癌症的认知、对HPV疫苗接种的态度以及疫苗接种率。这项横断面研究在萨卡里亚大学培训与研究医院开展，采用由被诊断为尖锐湿疣的患者填写的问卷。共有105名受访者纳入研究，其中80名男性（76.2%）和25名女性（23.8%）。参与者的平均年龄为34.7±11.2岁。HPV知晓率为70.5%，而宫颈癌知晓率为38.1%。与男性相比，女性对HPV和宫颈癌的知晓水平显著更高，对巴氏涂片检查的知识了解也更多。女性表达为其子女接种HPV疫苗意愿的可能性也显著高于男性（84.0%对58.8%，p=0.039）。较高的教育水平与对HPV的认知增加、HPV疫苗接种以及为子女接种疫苗的意愿相关。医生是整个队列中HPV相关信息的主要来源。HPV疫苗知晓率为73.3%，但总体疫苗接种率仅为10.5%，女性的疫苗接种率显著高于男性（24%对6.2%，p=0.021）。最常报告的疫苗接种障碍是费用（60%）和信息缺乏（45.7%）。没有参与者为其子女接种过疫苗。本研究强调，对HPV及其疫苗接种的认知与性别和教育水平相关，但并未转化为更高的疫苗接种率。应通过加强医生在公共教育中的作用，将重点放在针对男性和教育程度较低的个体上。将HPV疫苗接种纳入国家计划并开展符合文化特点的宣传活动可能有效提高疫苗接种率。
